Holen Sie sich die Stockscreener-App
4.64
4.72%
-0.23
Schlusskurs vom Vortag:
$4.87
Offen:
$4.75
24-Stunden-Volumen:
23,043
Relative Volume:
0.27
Marktkapitalisierung:
$26.41M
Einnahmen:
$257.00K
Nettoeinkommen (Verlust:
$-3.07M
KGV:
-4.8704
EPS:
-0.9527
Netto-Cashflow:
$-1.40M
1W Leistung:
-8.84%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.50
$4.75
1-Wochen-Bereich:
$4.50
$5.45
52-Wochen-Spanne:
$4.00
$6.20
Optimi Health Corp Stock (OPTH) Company Profile
Compare OPTH vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPTH
Optimi Health Corp
|
4.695 | 27.40M | 257.00K | -3.07M | -1.40M | -0.9527 |
TAK
Takeda Pharmaceutical Co Adr
|
16.98 | 53.37B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.845 | 42.80B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.60 | 41.09B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.03 | 31.62B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
558.72 | 23.23B | 3.17B | 1.29B | 1.01B | 27.09 |
Optimi Health Corp Aktie (OPTH) Neueste Nachrichten
SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits
Optimi Health Corp. - The Canadian Securities Exchange (CSE)
Optimi Health Corp. (OPTH) Stock: Surges 8% as Psilocybin Shipments to Australia Signal Growing Commercial Momentum - parameter.io
Optimi Health completes psilocybin export to Australia for patients with treatment-resistant depression - MSN
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression - PR Newswire
Optimi Health (NASDAQ: OPTH) makes third psilocybin shipment for TRD - Stock Titan
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression - GlobeNewswire Inc.
Price to earnings forward of Optimi Health Corp. – CSE:OPTI - TradingView
Price to sales forward of Optimi Health Corp. – LSX:A411WC - TradingView
Optimi Health Corp. (OPTH) Cash From Operations (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Market Cap - Zacks Investment Research
Optimi Health (OPTH) Stock Trends and Sentiment 2026 - MarketBeat
OPTH Price Today: Optimi Health Corp. Stock Price, Quote & Chart | MEXC - MEXC
OPTH|Optimi Health Ord Shs|Price:4.060|Chg%:0.05 - TradingKey
Price to book ratio of Optimi Health Corp. – TRADEGATE:8BN0 - TradingView
Optimi Health Corp. (OPTH) Book Value - Zacks Investment Research
Optimi Health Corp. (OPTH) Earnings Yield (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Price To Free Cash Flow - Zacks Investment Research
Optimi Health Corp. (OPTH) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
Optimi Health Corp. (OPTH) Free Cash Flow (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Total Expenses (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Shareholders Equity (Quarterly) - Zacks Investment Research
Optimi Health Corp. (OPTH) Net Income (Quarterly) - Zacks Investment Research
Optimi Health Corp. (OPTH) Ps Ratio (TTM) - Zacks Investment Research
Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research - GuruFocus
Inside the new tiny-dose psilocybin pills labs will test in studies - Stock Titan
Optimi Health (OPTH) Earnings Date and Reports 2026 - MarketBeat
Optimi Health completes production of microdose psilocybin products By Investing.com - Investing.com Nigeria
Optimi Health completes production of microdose psilocybin products - Investing.com
Optimi Health (NASDAQ: OPTH) debuts standardized psilocybin microdose capsules for research - Stock Titan
OPTH News | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill
Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel - Yahoo Finance
Optimi Health ships psilocybin to UK for clinical trial By Investing.com - Investing.com India
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial - GuruFocus
Optimi Health ships psilocybin to UK for clinical trial - Investing.com
Optimi Health Completes First Psilocybin Export to UK for Planned Phase 2 Trial - citybuzz -
Optimi Health exports psilocybin to UK for clinical trial By Investing.com - Investing.com South Africa
Optimi Health exports psilocybin to UK for clinical trial - Investing.com UK
Optimi Health Completes First Export of Psilocybin to UK - marketscreener.com
Optimi Health Corp. Completes First Export of Psilocybin to the UK for Phase 2 Clinical Trial - Quiver Quantitative
Finanzdaten der Optimi Health Corp-Aktie (OPTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):